Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.
3.

Circulating methylated DNA.

Herman JG.

Ann N Y Acad Sci. 2004 Jun;1022:33-9.

PMID:
15251936
4.

Molecular diagnostic applications of DNA methylation technology.

Cottrell SE.

Clin Biochem. 2004 Jul;37(7):595-604. Review.

PMID:
15234241
5.

Methylated genes as new cancer biomarkers.

Duffy MJ, Napieralski R, Martens JW, Span PN, Spyratos F, Sweep FC, Brunner N, Foekens JA, Schmitt M; EORTC PathoBiology Group.

Eur J Cancer. 2009 Feb;45(3):335-46. doi: 10.1016/j.ejca.2008.12.008. Epub 2009 Jan 12.

PMID:
19138839
6.

Gene promoter methylation--a potential cancer marker.

Ze-Jun- L, Masato M.

Adv Clin Path. 2002 Jan;6(1):43-6. Review. No abstract available.

PMID:
17582948
7.

Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA.

Korshunova Y, Maloney RK, Lakey N, Citek RW, Bacher B, Budiman A, Ordway JM, McCombie WR, Leon J, Jeddeloh JA, McPherson JD.

Genome Res. 2008 Jan;18(1):19-29. Epub 2007 Nov 21.

8.

Analysis of methylated circulating DNA in cancer patients' blood.

Sunami E, Vu AT, Nguyen SL, Hoon DS.

Methods Mol Biol. 2009;507:349-56. doi: 10.1007/978-1-59745-522-0_25.

PMID:
18987826
9.
10.

Strategic approach to validating methylated genes as biomarkers for breast cancer.

Wang W, Srivastava S.

Cancer Prev Res (Phila). 2010 Jan;3(1):16-24. doi: 10.1158/1940-6207.CAPR-09-0098. Review.

11.

Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.

Zon G, Barker MA, Kaur P, Groshen S, Jones LW, Imam SA, Boyd VL.

Anal Biochem. 2009 Sep 15;392(2):117-25. doi: 10.1016/j.ab.2009.06.001. Epub 2009 Jun 6.

PMID:
19505431
13.

Use of DNA methylation for cancer detection: promises and challenges.

Zhu J, Yao X.

Int J Biochem Cell Biol. 2009 Jan;41(1):147-54. doi: 10.1016/j.biocel.2008.09.003. Epub 2008 Sep 13. Review.

PMID:
18834953
14.

Biomarkers in cancer screening: a public health perspective.

Srivastava S, Gopal-Srivastava R.

J Nutr. 2002 Aug;132(8 Suppl):2471S-2475S. Review.

15.

Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy.

Martínez-Galán J, Torres B, Del Moral R, Muñoz-Gámez JA, Martín-Oliva D, Villalobos M, Núñez MI, Luna Jde D, Oliver FJ, Ruiz de Almodóvar JM.

Cancer Biol Ther. 2008 Jun;7(6):958-65. Epub 2008 Mar 20.

PMID:
18379196
16.

Challenges for biomarkers in cancer detection.

Wagner PD, Verma M, Srivastava S.

Ann N Y Acad Sci. 2004 Jun;1022:9-16.

PMID:
15251933
17.

Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.

Lotze MT, Wang E, Marincola FM, Hanna N, Bugelski PJ, Burns CA, Coukos G, Damle N, Godfrey TE, Howell WM, Panelli MC, Perricone MA, Petricoin EF, Sauter G, Scheibenbogen C, Shivers SC, Taylor DL, Weinstein JN, Whiteside TL.

J Immunother. 2005 Mar-Apr;28(2):79-119.

PMID:
15725954
18.

DNA methylation biomarkers in cancer: progress towards clinical implementation.

Mikeska T, Bock C, Do H, Dobrovic A.

Expert Rev Mol Diagn. 2012 Jun;12(5):473-87. doi: 10.1586/erm.12.45. Review.

PMID:
22702364
19.

PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment.

Kristensen LS, Hansen LL.

Clin Chem. 2009 Aug;55(8):1471-83. doi: 10.1373/clinchem.2008.121962. Epub 2009 Jun 11. Review.

20.

Imaging as a Biomarker: Standards for Change Measurements in Therapy workshop summary.

Clarke LP, Sriram RD, Schilling LB.

Acad Radiol. 2008 Apr;15(4):501-30.

PMID:
18389935

Supplemental Content

Support Center